Casimiro C, Rodrigo J, Mendiola M A, Rey F, Barrios A, Gilsanz F
Medical Department, Abbott Laboratories Spain, Madrid, Spain.
Minerva Anestesiol. 2008 Jul-Aug;74(7-8):381-91. Epub 2008 Apr 18.
To compare the anaesthetic epidural effects of levobupivacaine plus fentanyl versus bupivacaine plus fentanyl in patients undergoing lower limb surgery.
A single blind, randomised, prospective, multicentre study was designed to compare both therapies. The study was conducted in 10 tertiary hospitals. A total of 96 patients who were ASA I or II, who required at least a 24-hour-stay in the hospital and who were subjected to surgery of lower limbs with epidural anaesthesia were enrolled in this study. Treatments were administered at a dosage of 1.2 ml per metamera,including a test dose (3 mL) and the dose of fentanyl (100 mg). Patients were then randomly allocated to receive either Levobupivacaine (n = 49) or bupivacaine (N.= 47). The primary endpoint was sensory blockade (SB) duration. Secondary evaluations included motor blockade (MB), post-surgery analgesic medication usage, safety and the investigator global evaluation.
SB duration was similar for both interventions: 195 min (165-205) in the bupivacaine group versus 170 min (140-185) in the levobupivicaine group (log-rank test, P=0.884). However, the lack of MB as evaluated by the modified Bromage scale was significantly higher in the levobupivacaine group than in the bupivacaine group (39% vs 13%, P=0.017). Although no significant differences in MB duration were observed between the groups, a trend was observed in the levobupivacaine group, which had a lesser MB (P=0.093). Investigator satisfaction was high and was assessed to a similar extent for both interventions. Forty-one adverse events were detected in 28 patients, with no differences between groups: 15 (33%) with bupivacaine and 13 (27%) with levobupivacaine, P=0.516.
Although both interventions showed similar anaesthetic effects, a higher proportion of patients receiving levobupivacaine lacked MB.
比较左旋布比卡因加芬太尼与布比卡因加芬太尼用于下肢手术患者的硬膜外麻醉效果。
设计一项单盲、随机、前瞻性、多中心研究以比较两种治疗方法。该研究在10家三级医院进行。共有96例美国麻醉医师协会(ASA)分级为I或II级、需住院至少24小时且接受硬膜外麻醉下下肢手术的患者纳入本研究。给药剂量为每节段1.2 ml,包括试验剂量(3 ml)和芬太尼剂量(100 mg)。然后将患者随机分为接受左旋布比卡因组(n = 49)或布比卡因组(n = 47)。主要终点为感觉阻滞(SB)持续时间。次要评估包括运动阻滞(MB)、术后镇痛药物使用情况、安全性及研究者整体评估。
两种干预措施的SB持续时间相似:布比卡因组为195分钟(165 - 205),左旋布比卡因组为170分钟(140 - 185)(对数秩检验,P = 0.884)。然而,根据改良的布罗麻量表评估,左旋布比卡因组运动阻滞缺乏的比例显著高于布比卡因组(39%对13%,P = 0.017)。尽管两组间运动阻滞持续时间未观察到显著差异,但左旋布比卡因组有运动阻滞较轻的趋势(P = 0.093)。研究者满意度较高,两种干预措施的评估程度相似。在28例患者中检测到41例不良事件,组间无差异:布比卡因组15例(33%),左旋布比卡因组13例(27%),P = 0.516。
尽管两种干预措施显示出相似的麻醉效果,但接受左旋布比卡因的患者中运动阻滞缺乏的比例更高。